Poland· PL-100506620
Piteromib
A combinations of various lipid modifying agents product containing pitavastinum calicum + ezetimibum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pitavastinum calicum + ezetimibum is registered in 2 of 19 countries.
Countries holding a registration under ATC C10BA (combinations of various lipid modifying agents), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Pitavastinum calicum + ezetimibum · ATC C10BA
2 / 19 countries
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Pitavastinum calicum + Ezetimibum
- Manufacturer
- Krka, d.d., Novo mesto
- Country
- Poland (PL)
- ATC code
- C10BA
- ATC class
- Combinations of various lipid modifying agents
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin03838989789084
- gtin03838989789091
- gtin03838989789107
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pitavastinum calicum + ezetimibum in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPITEZENIBKrka, d.d., Novo mesto, Novo mesto
- SpainEZELPIX 2 MG/10 MG CÁPSULAS DURASTecnimede España Industria Farmaceutica S.A.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Ко-Питипикс
- Cyprus · Pitavastatin/Ezetimibe Tad
- Czechia · Pitezenib
- Spain · Ezelpix, Pitavastatina/Ezetimiba Krka
- Greece · Co-Pitavador
- Lithuania · Pitezenib
- Portugal · Ezepix, Pitetimb
- Romania · Co-Pitipix
- Slovenia · Piteromib
- Slovakia · Pitezenib
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5ab8719-813d-418d-b220-69ddbee6bd57 GET /v1/drugs/c5ab8719-813d-418d-b220-69ddbee6bd57?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "2 mg + 10 mg",
"packaging": "03838989789084 ¦ Rp ¦ 165446\n30 tabl.\n03838989789091 ¦ Rp ¦ 165447\n60 tabl.\n03838989789107 ¦ Rp ¦ 165448\n90 tabl.",
"substance": "Pitavastinum calicum 2 mg + Ezetimibum 10 mg",
"common_name": "Pitavastinum calicum + Ezetimibum",
"pl_product_id": "100506620",
"pozwolenie_nr": "29658",
"auth_procedure": "DCP",
"authorisation_validity": "2031-04-21"
}See everything about pitavastinum calicum + ezetimibum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.